Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GUIDE-AF

Financiado

Cerrado

Personalized Phenotype of Atrial Fibrillation for Accurate Treatment

Atrial Fibrillation (AF) is the most common cardiac arrhythmia with an EU health cost of 13.5 billion annually. Despite the worsening that this cardiac arrhythmia provokes on the life quality of more than 6 million Europeans, AF t... ver más

19/04/2021

204K€

Presupuesto del proyecto: 204K€

Líder del proyecto

UNIVERSITAT DE VALÈNCIA (ESTUDI GENERAL) No se ha especificado una descripción o un objeto social para esta compañía.

Sin perfil tecnológico

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-04-19

MSCA-IF-2020: Individual Fellowships

I+D

Cerrada hace 4 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

204.42K€ | Lider

BOARD OF TRUSTEES OF THE LEL...

STANFORD

123.95K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EUTRAF The European Network for Translational Research in Atrial Fi... 16M€ Cerrado

EIN2020-112359 INCREASING THE EFFICACY OF ATRIAL FIBRILLATION TREATMENT AND... 15K€ Cerrado

EUIN2017-88214 TERAPIAS PERSONALIZADAS PARA LA FIBRILACION AURICULAR. UNA R... 25K€ Cerrado

DPI2017-83952-C3-1-R ESTUDIO MULTICENTRICO PARA LA EVALUACION DEL SUSTRATO ARRITM... 157K€ Cerrado

PersonalizeAF Personalized Therapies for Atrial Fibrillation. A Translatio... 4M€ Cerrado

CATCH ME Characterizing Atrial fibrillation by Translating its Causes... 5M€ Cerrado

Líder del proyecto

UNIVERSITAT DE VALÈNCIA (ESTUDI GENERAL) No se ha especificado una descripción o un objeto social para esta compañía.

Sin perfil tecnológico

Presupuesto del proyecto 204K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Atrial Fibrillation (AF) is the most common cardiac arrhythmia with an EU health cost of 13.5 billion annually. Despite the worsening that this cardiac arrhythmia provokes on the life quality of more than 6 million Europeans, AF therapies are suboptimal: success rate is below 60% including pharmacological and surgical approaches. AF is a multifactorial and progressive disease with high patient heterogeneity and therefore the same treatment for all is not optimal. GUIDE-AF addresses this challenge by a multi-sectorial and multidisciplinary research and training program in novel technologies for the individualization of the AF phenotype with the aim to increase treatments’ efficiency. GUIDE-AF will integrate data and knowledge from anatomical, biological, biomechanical and electrophysiological approaches to generate an accurate description of the patient-specific disease phenotype. The effect of the different AF treatments will be described and quantified for each AF phenotype in order to provide the best therapy choice. GUIDE-AF project will build a machine learning-based decision support system able to characterize the disease state and progression and able to predict the outcome of therapies. This algorithm will be based on technologies co-developed and validated by the candidate and the host and beneficiary research groups. GUIDE-AF will count with experts in cardiac arrhythmia management, AF characterization through image and signal analysis, basic and clinical research, as well as access to one of the largest AF patient database. GUIDE-AF will have an eminently multidisciplinary and clinical approach and will focus on providing a feasible and implantable solution for increasing the therapy success and reducing human and health system costs. This proposal includes intensive training for the candidate in new advanced technologies for cardiac characterization and disease profiling, as well as knowledge transfer from and to the host and beneficiary institutions.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores